Late-Breaking Call for Papers

Late-Breaking Abstract Submission Deadline
All submissions, including processed payments, must be completed by this time:
Wednesday, October 28, 2020 11:59PM (PDT)

Use the links on the left to navigate this page or access further information on the ASH Web site. Complete call for abstracts information can be found on the ASH site.

Eligibility

To submit an abstract, the following criteria must be met

• Only six abstracts will be accepted and presented in the Late-Breaking abstracts session on Tuesday, December 10, 2024, from 7:30 – 9:00 AM Pacific Time. Authors should realize that selection for presentation is extremely competitive, with the quality and general significance of the presented Late-Breaking abstracts equivalent to Plenary Session or very top oral session abstracts. Case reports and interim trial results are NOT appropriate for Late-Breaking Abstract Submission.
• Late-breaking abstracts should highlight novel and substantive studies of high impact. The late-breaking abstract deadline is not intended to be merely an extension of the general submission deadline and will focus on capturing abstracts with ground-breaking and novel data that otherwise could not be presented at the annual meeting.
• The selection process will be highly competitive; no more than six abstracts will be selected for an oral presentation in a late-breaking abstracts session on Tuesday morning of the ASH annual meeting.
• Examples of suitable late-breaking abstracts might include the results of a practice-changing prospective clinical trial or the discovery of a mechanism underlying or characterizing a disease process (such as the JAK2 mutation in myeloproliferative disorders), which were not fully available by the general abstract submission deadline.
• Late-breaking abstracts are not eligible for oral or poster presentation in the regular ASH annual meeting abstract program. Late-breaking abstracts will not be chosen from among the abstracts submitted by the general submission deadline, but all other ASH policies stated in the general submission abstracts will still apply.
• The accepted late-breaking abstracts will be published online.
• At least one of the authors must be an ASH member, who has paid the current membership dues.

  If none of the abstract authors is an ASH member, the abstract must be sponsored by a current ASH member or it will not be reviewed. ASH members are urged to use their judgment in restricting sponsorship to a reasonable number of abstracts, keeping in mind that they are endorsing the authenticity and quality of each abstract that they sponsor.

• Research and/or studies must fit into one of the ASH 2020 Abstract Review Categories.

Any of the following criteria will make an abstract ineligible for presentation at the ASH annual meeting

• Data are publicly available via major search engines (such as PubMed, Google Scholar, etc.);
• Data are accepted for publication before the abstract submission closing date of October 28, 2024. Any abstract submission accepted for publication before October 28 must be withdrawn.
• Data have been or are to be presented at a meeting of 3,000 or more participants before the 2024 ASH annual meeting.
• Data are to be presented at an ASH Friday Satellite Symposium, scheduled for December 6, 2024.

*Note: Updated analyses of work previously presented at ASH or other meetings of more than 3,000 participants will be considered only if the abstract is a significant extension of previously published or presented work. The author must provide an explanation documenting the significant new information.

Responsibilities of the Presenting Author

• Once an abstract is accepted, the presenting author is the sole contact for all correspondence regarding the abstract, unless otherwise specified under the “Contact Information” section of the online abstract submission system.
• The presenting author must be one of the co-authors listed on the submitted abstract.
• The presenting author is responsible for the following:
• Ensuring that all authors have read the abstract and agreed to be co-authors. Failure to get approval from all authors will result in rejection of the abstract.
• Notifying all co-authors of any additions, deletions, and changes to the program, as may be communicated by ASH.
• Ensuring all co-authors provide conflict-of-interest disclosures and copyright transfer information.
• Forwarding all correspondence from ASH to all co-authors, including the ASH policies and guidelines, relating to disclosure of financial relationships.

Technical Requirements

The electronic submission system is compatible with PC Windows and Apple computers and with most browsers, including Google Chrome, Mozilla Firefox, Internet Explorer, Safari, and Netscape.

Before you Begin

Have the following information available:

Submission Process

FAQS

Please consider the following before submitting your abstract to the ASH Annual Meeting:

• Q: What is the submission deadline for late-breaking abstracts?

  A: The submission deadline for late-breaking abstracts is October 28, 2020 at 11:59 p.m. PDT. You may make changes to your abstract up until this deadline, however, absolutely no changes (including to the author list) can be made after this deadline.

• Q: How much is the late-breaking abstract submission fee?

  A: A: The submission fee is $125 for late-breaking abstracts. Abstract payment does NOT include registration to the Annual Meeting.

• Q: Once I start or complete a submission, will I be able to make changes?

  A: A: Yes, you may save a partial submission in the system to complete later or go back and modify anything in your submission up until the late-breaking abstract submission deadline, October 28, 2024, at 11:59 PM Pacific time. Absolutely no changes may be made after this deadline, including to author lists.

• Q: Can I still submit an abstract if I presented it at another scientific meeting or submitted it to a journal?

  A: Any of the following criteria will make an abstract ineligible for presentation at the ASH annual meeting:

  • Data from peer-reviewed content publicly available via major search engines (such as PubMed, Google Scholar, etc.),
  • Data are accepted for journal publication before the ASH late-breaking abstract submission closing date, October 28, 2024. Any abstract submission accepted for publication before October 28, 2024, must be withdrawn.
  • Data have been or are to be presented at a meeting of 3,000 or more participants before the 2020 ASH annual meeting.
  • Data are to be presented at an ASH Friday Satellite Symposium, scheduled for December 6, 2024.

  *Updated analyses of work previously presented at other ASH or professional/scientific meetings of more than 3,000 participants will be considered only if the abstract is a significant extension of previously published or presented work. The author must provide an explanation documenting the significant new information during submission.

• Q: How long can the abstracts be?

  A: The abstracts are limited to a maximum of 3,800 characters.

• Q: May I include tables in my abstract?

  A: No, tables are not permitted in abstracts.

• Q: May I include figures in my abstract?

  A: No, figures are not permitted in abstracts.

• Q: How many abstracts can a single author submit?

  A: There is no set limit as to the number of abstracts a single author can submit.

• Q: Is there a limit on the number of authors that can be listed on a submission?

  A: No, there is no limit on the number of authors per abstract.

• Q: Do all authors on an abstract have to submit their Conflict-of-Interest disclosures to ASH? How should they do that?

  A: Yes, the submitting author must manually enter disclosure information for all authors into the online abstract submission form. Authors must disclose their relationships, regardless of their relevance to an abstract. If an author's COI disclosure form populates with information already supplied, we strongly urge you to use this existing information for that person. If you are aware of a relationship that should be added to that disclosure, you may do so, and the update will be applied to all of that individual's disclosures for the entire meeting.

  Please do NOT delete any existing disclosure information if you are not the person in question. You can use this sample form to collect disclosure information from your coauthors. (Please note that this form should NOT be sent to ASH; you are responsible for entering the information on the form into the online abstract submission system for every author.)

• Q: My co-authors and I are employed by a privately-held healthcare company. Can we submit an abstract?

  A: Yes. Oral abstract and poster presentations are not a part of the ACCME-accredited portion of the annual meeting. Therefore, presenting authors are not subject to ACCME restrictions, and can be employees of publicly- traded or privately-held healthcare companies or owners of privately-held entities. All relevant conflicts of interest must be disclosed, and data presented fairly and transparently.

• Q: Is there a limit to the number of abstracts an ASH Member can sponsor?

  A: No, ASH members are not limited in the number of abstracts they can sponsor.

• Q: What if I need to withdraw my late-breaking abstract?

  A: Authors can withdraw a submission via the submission system any time before the October 28, 2024, 11:59 PM Pacific time late-breaking abstract submission deadline. After the deadline, requests for withdrawal must be submitted in writing, by the Presenting Author to ASHabstracts@hematology.org.

• Q: What if I need to make a correction to my late-breaking abstract?

  A: You may make corrections up until the late-breaking abstract submission deadline, October 28, 2024, 11:59 PM Pacific time. If you submit before the deadline, you will be able to make edits until the submission window closes. To ensure the integrity of the review process, corrections to abstracts will not be allowed after the abstract submission deadline. This includes corrections to author names and order of authors.

• Q: When will I know if my late-breaking abstract has been accepted?

  A: The presenting author will be notified no later than November 18, 2024.

• Q: When will my accepted late-breaking abstract be published?

  A: Accepted late-breaking abstracts will be made available online on November 25, 2024, on the ASH annual meeting Program Web site. They will also be published in a mid-November supplemental issue of Blood.

• Q: Will selected late-breaking abstracts be presented?

  A: Yes. The six selected late-breaking abstracts will be presented at the Annual Meeting on Tuesday, December 10, 2024, from 7:30 – 9:00 AM Pacific time.

• Q: Can an administrator submit on behalf of authors (i.e., the submitter is not listed as an author in the system, only using their account to submit on behalf of the authors they are assisting)?

  A: Yes, this is very common. However, only the submitter can access the submission (SSO enforces this), and if the abstract is accepted, all subsequent notifications and correspondence will be addressed to the presenting author.

• Q: Are clinical case studies appropriate for LBA submissions?

  A: No.

• Q: Are Trials in Progress appropraite for LBA submission?

  A: No.

• Q: Do I transfer copyright to my late-breaking abstract to ASH?

  A: As of submission, authors assign copyright of the abstract to ASH, unless one of the authors is a U.S. Federal employee (in such case, ASH does not hold copyright). This means that the identical abstract may not be republished or submitted to another meeting. Materials presented at the ASH Annual Meeting or requested for submission by ASH in conjunction with the annual meeting such as PowerPoint Slides and Posters are the intellectual property of individual presenters or entities other than ASH, however upon acceptance for presentation, the author(s) grant ASH the exclusive, world-wide right to license such materials. The full copyright and re-use policy, including rights granted to authors, can be found at https://www.hematology.org/meetings/annual-meeting/abstracts/copyright-and-reuse-policy

• Q: Is my submission subject to embargo? If so, when does the embargo lift?

  A: Yes, late-breaking abstracts are embargoed from the time of submission. This means that the data in the abstract cannot be published in a journal once submitted for the ASH annual meeting until the meeting has concluded.

  The information contained in all accepted late-breaking abstracts are posted online on Monday, November 25, 2024, at 9:00 AM Eastern time. At these times, the embargo will lift on the data within the abstract, including the abstract title, presentation date and time, and authors.

  Information that goes beyond that which is contained within the “four corners” of the late-breaking abstract as posted online are embargoed until the abstract is first made publicly available online the week of the annual meeting. Late-breaking abstracts are not presented at the annual meeting.